-
Nocturnal 'coffee frog' discovered in Costa Rica
-
Defending champion Shelton storms to Montreal win
-
India's 'cockroach' protest movement keeps heat on Modi
-
Exodus: West Bank hardships drive out Palestinian Christians
-
Russia's only anti-war party eyes support boost at elections
-
Travis Head wins Australian cricketer of the year gong
-
Canada tries to adapt to a future of wildfires
-
Colombia's new president vows to 'defeat narco-terrorists'
-
Death of NBA forward Clarke ruled accident due to heroin, cocaine
-
Call for Infantino to resign comes amid wave of support
-
Abelardo de la Espriella, Colombian president and flamboyant millionaire
-
Trump ally Abelardo de la Espriella sworn in as Colombia president
-
Maradona's 'Hand of God' ball heads to US auction
-
FIFA chief Infantino gets backing of South American football
-
Rybakina advances while Andreeva exits at Toronto
-
Amazon behind massive private gas plant for new data centers
-
Shelton storms to Montreal win as title defence solidifies
-
Apple and OpenAI escalate legal battle over devices
-
All Blacks need to improve says coach after opening win against Stormers
-
All Blacks strike late to secure opening win against Stormers
-
Spain imposes border checks on Italy as migrant showdown grows
-
Saudi Arabia, Turkey, Pakistan sign defence pact amid regional war
-
Bezzecchi smashes Silverstone track record in MotoGP qualifying
-
Trump renews effort to remove US Fed Governor Lisa Cook
-
Rashid Khan takes six wickets as Afghanistan thrash Ireland
-
Abelardo de la Espriella, the flamboyant millionaire taking power in Colombia
-
Flintoff quits England Lions role after Sydney Thunder appointment
-
Germany holds security meeting over explosive drone amid Russia protest
-
Movement, El Vecino and RISE Partner to Launch First Digital Dollar Wallet for Mexican Remittances
-
Austrian writer Stefan Zweig, who fled Nazis, honoured in London
-
FIFA chief Infantino travels to Colombia for presidential inauguration
-
Mexico and Peru reestablish ties after asylum spat
-
Niewiadoma seizes Tour de France Femmes lead on Mont Ventoux
-
Dollar drops, stocks climb as weak US jobs data eases rate fears
-
Trump's ex-lawyer all set for confirmation as US attorney general
-
Japan defender Tomiyasu joins Crystal Palace
-
WHO urges Ervebo vaccine trial in DR Congo Ebola outbreak
-
Celtic boss O'Neill out of hospital after 'small procedure'
-
Hardline Trump ally De la Espriella to take office in Colombia
-
Man City reject Barcelona bid for Rodri - reports
-
Cambridge to review hiring process amid plagiarism row
-
US unexpectedly loses jobs in blow to Trump ahead of midterms
-
STARTRADER in Discussions with Trustpilot to Consolidate Review Profiles
-
Dollar drops, stocks climb after surprise US jobs miss
-
US unexpectedly loses jobs in blow to Trump's economy claims
-
Thai students in disbelief after deadly school shooting
-
Call for Infantino to resign comes in wake of wave of support
-
McLaren boss glad of 'harmony' between F1 teammates Norris and Piastri
-
Gaza beekeeper starts again on rooftop amid ruins of war
-
Saudi Arabia, Turkey and Pakistan sign defence pact amid regional war
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence
With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.
ATLANTA, GA / ACCESS Newswire / October 23, 2025 / Florence Healthcare reinforced its position as the global leader in clinical trial operations with a major milestone: Florence Trial Operations Platform now connects 65,000 study sites spanning more than 600 sponsors across 90+ countries, forming the industry's largest network. Recognized as the #1 clinical trial technology for six consecutive years, Florence continues to set the standard for startup speed, workflow automation, and operational risk management across sponsor study portfolios.
"Florence was built to bring sponsors and sites into a shared operational space," said Ryan Jones, CEO of Florence Healthcare. "First, we fully digitized startup to eliminate manual bottlenecks and paper workflows. Now, we're using AI to enhance speed and augment intelligence across 65,000 study sites globally - arming sponsors with portfolio-wide operational visibility so they can anticipate trial risk, act on insights, and drive execution on the ground."
Solving the $1 million per study problem
While digital-first sites set new standards for operational speed and efficiency, much of the industry still remains offline. Only 30% of global sites currently use an eISF, leaving roughly 200,000 sites dependent on inefficient paper processes for study startup, document collection and storage, regulatory process management, monitoring and closeout.
This lack of digitization costs sponsors an estimated $1 million per study in lost productivity, rework, quality and compliance risk.
Florence is closing this digital divide through the fastest growing clinical research network of 65,000 study sites and 600+ sponsors. By digitizing 100% of operational workflows, Florence sets the standard for startup speed, operational cost reduction, and risk control.
The results are compelling:
Up to 70% faster last mile study startup operations compared to the average site startup time for a Top 10 global pharmaceutical sponsor.
$141M annual operational cost takeout by automating site readiness workflows, based on active daily users and total hours saved per year across Florence's study site network.
51% increase in eTMF QA pass rates from 65% to 98.7%, due to built-in operational audits and automated compliance checks to control risk.
Shaping the Future of Study Operations
Florence is embedding AI across the study lifecycle to unlock operational data intelligence, recommend next-best actions, strengthen risk control, and improve operating efficiency.
Site Identification & Feasibility
Drawing on the industry's largest network of site intelligence, Florence enables sponsors and CROs to identify the most qualified sites by therapeutic area, geography, and performance, while AI-assisted feasibility surveys ensure faster, more accurate completion.
Study Startup
AI-enabled contracting and document exchange between eTMF and eISF automates SSU document exchange, while generative AI redlining shortens contract review cycles, compares terms in seconds, and dramatically reduces time to activation.
Remote Monitoring
AI-powered reporting surfaces early risk signals from operational audit trails and site data, providing real-time visibility and enabling proactive intervention. These insights minimize the need for on-site visits and ensure trials stay on schedule.
Together, these advancements move sponsors and CROs from manual oversight to intelligent execution across global study portfolios. Through its open API network, Florence rapidly integrates and extends its trial operation capabilities to other eClinical partner systems.
Florence AI operates at the speed of trust, ensuring every study remains fully aligned with FDA, EMA, HIPAA, GDPR, EU Annex 11, ICH E6 (R3), and GCP standards.
All capabilities will be available in December 2025.

Join the Movement: Research Revolution 2025
Florence will showcase its newest capabilities at Research Revolution 2025, the company's annual global event (October 26-28, 2025) bringing together sponsors, CROs, and research sites. Be part of the global revolution. Watch it live at: https://researchrevolutionsummit.com/live/
About Florence Healthcare
Florence is a purpose-built platform that connects sponsors and sites to accelerate clinical trials, improve operational capacity, and reduce risk. Designed for scale, Florence streamlines workflows, enhances collaboration, and delivers real-time visibility across studies-empowering research teams to move faster, stay inspection-ready, and increase trial throughput with fewer resources.
Contact Information
Seema Sheth-Voss
[email protected]
(888) 829-0896
SOURCE: Florence Healthcare
View the original press release on ACCESS Newswire
J.Bergmann--BTB